JDBIO Participates in AMWC Monaco 2026
Strong Reception for New Skin Booster and Toxin Products, Strengthening Global Presence as a Gold Sponsor
JDBIO, a global leader in medical aesthetics, participated in AMWC Monaco 2026, one of the world’s most prestigious conferences in aesthetics and anti-aging, held at the Grimaldi Forum in Monaco from March 26 to 28. The company showcased its proprietary technologies and demonstrated the competitiveness of its product portfolio.
AMWC Monaco is a globally recognized academic event that brings together over 10,000 medical professionals and more than 500 speakers each year. With a strong focus on practicing clinicians, it serves as a key platform in the medical aesthetics field—offering real-time insights into the latest clinical trends while enabling immediate feedback on products from the market.
At this year’s event, JDBIO participated as a Gold Sponsor, further elevating its global brand presence. The company drew significant attention with a large-scale booth located near the entrance of the high-traffic Atrium Hall. The booth featured a refined design that reflected the brand’s identity, enhancing the overall exhibition experience and attracting visitors from around the world.
Throughout the exhibition, JDBIO’s booth saw a steady stream of global buyers. In-depth export consultations and contract discussions were actively conducted, particularly around its newly launched toxin and skin booster lineup. Key products included RICHESSE™ TRINITY90 with RH, a multi-skin booster combining RH collagen, PN, PDRN, and HA; RICHESSE™ TX, a high-purity botulinum toxin; DEMEI™ PLA/PCL, a next-generation polymer-based skin booster; and DEMEI™ BODY 60/100, a high-purity hyaluronic acid body filler. The unveiling of these new products further strengthened the company’s portfolio for global market expansion.
Medical professionals from around the world praised the high quality and strong price competitiveness of Korean medical aesthetics products. In particular, there was notable interest in the exosome-based skin booster line, while products formulated with PN ingredients also demonstrated steady demand. Meanwhile, RICHESSE™ Red Volume, a lip-specific filler, gained strong popularity among practitioners from Latin America, contributing to positive feedback across the entire product range.
Through its participation in AMWC Monaco 2026, JDBIO reaffirmed the strong trust it has earned from the global medical community. Moving forward, the company aims to continue its growth as a global total beauty solutions provider—encompassing both medical aesthetics and cosmetics—through ongoing R&D and active participation in international academic and exhibition platforms.